Related Experiment Video
Updated: Jun 8, 2026
09:12
Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
Published on: May 11, 2018
Implementation of p22 viral capsids as nanoplatforms
Sebyung Kang1, Masaki Uchida, Alison O'Neil
1Department of Chemistry and Biochemistry and Center for Bio-Inspired Nanomaterials, Montana State University, Bozeman, MT 59717, USA.
Biomacromolecules
|September 16, 2010
Summary
Researchers engineered bacteriophage P22 viral capsids into novel nanoplatforms. These modified capsids can be internally functionalized to entrap large protein complexes like streptavidin.
Area of Science:
- Biochemistry
- Structural Biology
- Nanotechnology
Background:
- Viral capsids are dynamic protein shells that self-assemble and change shape.
- Bacteriophage P22 capsids possess inherent structural flexibility suitable for nanoplatform development.
Purpose of the Study:
- To engineer bacteriophage P22 viral capsids into distinct nanoplatforms.
- To genetically modify the interior surfaces for site-specific biotin linker attachment.
- To characterize internal modifications and assess nanoplatforms' protein entrapment capabilities.
Main Methods:
- Genetic manipulation of bacteriophage P22 capsid interior surfaces.
- Site-specific attachment of biotin linkers.
- High-resolution mass spectrometry for characterizing internal modifications.
- Utilizing wiffle-ball (WB) nanoplatforms with 10 nm pores for streptavidin entrapment.
Main Results:
- Two morphologically distinct viral nanoplatforms were generated from P22 capsids.
- Internal modification reactivity varied with capsid structural transformations.
- Wiffle-ball (WB) nanoplatforms successfully entrapped streptavidin via biotin linkers.
Conclusions:
- Genetically engineered viral capsids serve as versatile nanoplatforms.
- Internal capsid surface modifications can be tailored for specific applications.
- Bacteriophage P22 capsids are promising scaffolds for nanotechnology and drug delivery systems.
